a formal metabolic study of carbenoxolone sodium ( biogastrone ) 300 mg./day has been performed for 17 days on a woman with gastric ulcer who in a previous 21-day trial , on a 52-meq sodium diet , showed weight gain , retention , and rise in plasma sodium and chloride concentrations , as well as hypokalaemia without change in potassium balance .
C0006980
carbenoxolone sodium
C0733684
biogastrone